Abstract
Even though it is known that the virus of hepatitis A may be transmitted by the parenteral route, 1 we hardly ever think of this possibility when hepatitis follows transfusion of blood or blood products. Almost invariably, we assume that the disease is hepatitis B. Meyers et al 2 remind us that this assumption can be misleading. They have investigated an outbreak of hepatitis in a bone marrow transplant unit. Overt disease developed within a period of three months in nine patients with a marrow transplant and in six donor-members of their families. Subclinical hepatitis, evidenced by increased serum glutamic oxalacetic transaminase concentrations, was detected in 21 additional cases among family members, staff members, and other donors, and 69% of patients receiving platelet transfusion during the period of risk. Unexpectedly, the short incubation period as well as the clinical and serological features of the illness were compatible with hepatitis A
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
